PAM
MBIO icon

Panagora Asset Management’s Mustang Bio MBIO Stock Holding History

Panagora Asset Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$2K – 2884
2021
Q1 		$2K Hold
1
– – ﹤0.01% 2716
2020
Q4 		$3K Hold
1
– – ﹤0.01% 2576
2020
Q3 		$2K Buy
+1
New +$2.46K ﹤0.01% 2587
2018
Q3 		– Hold
0
– -$1K – 2448
2018
Q2 		– Hold
0
– – – 2350

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Panagora Asset Management's MBIO Position: Q2 2021 in Review

Panagora Asset Management sold out of Mustang Bio (MBIO) in Q2 2021, closing a stake of 1 share — an estimated $2K sold.

Panagora Asset Management first reported a position in MBIO in Q3 2020 and held it in 3 quarters. The position peaked at $3K in Q4 2020. 92 funds tracked by Wall St. Rank hold MBIO as of Q2 2021.

  • Panagora Asset Management reported no remaining Mustang Bio position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 1 Mustang Bio share in Q2 2021, an estimated $2K.
  • Panagora Asset Management first reported a position in Mustang Bio in Q3 2020 and held it in 3 quarters.
  • Panagora Asset Management's Mustang Bio position peaked at $3K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.